Study Results Abstracts From Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) At 2025 ASCO Genitourinary Cancers Symposium CHENGDU, China, Feb. 13, 2025 /PRNewswire/ — At the American Society of… CISION PRNewswireFebruary 13, 2025
Press ReleaseSouthern Star Research Applauded by Frost & Sullivan for Delivering Comprehensive Clinical Trial Solutions and Its Competitive Strategies Southern Star sets itself apart in the CRO market through a unique… CISION PRNewswireFebruary 13, 2025
Press ReleaseMafengwo AI Intelligent Application Integrates with DeepSeek Model, Leading the Intelligent Transformation of the Tourism Industry BEIJING, Feb. 13, 2025 /PRNewswire/ — As DeepSeek’s cutting-edge technology rapidly expands… CISION PRNewswireFebruary 13, 2025
Press ReleaseLove is in the Air: Agoda Unveils Most Romantic Valentine's Day Destinations in Asia SINGAPORE, Feb. 13, 2025 /PRNewswire/ — Love is in full bloom as… CISION PRNewswireFebruary 13, 2025
Press ReleaseA New Japanese Cultural Experience by Isetan Shinjuku Experience Japanese Culture with All Five Senses at the "JAPAN SENSES" Campaign… CISION PRNewswireFebruary 13, 2025
Press ReleaseHD Korea Shipbuilding & Offshore Engineering Leads the Zero-Carbon Era with 'SMR-Powered Ship' – Received Approval in Principle (AIP) from the American Bureau of Shipping… CISION PRNewswireFebruary 13, 2025
Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC HONG KONG, Feb. 13, 2025 /PRNewswire/ — Akeso, Inc. (9926. HK) ("Akeso" or… CISION PRNewswireFebruary 13, 2025
KALiNA Power and Crusoe Sign Framework Agreement for Joint Development of Multiple Co-Sited AI Data Centre Projects in Alberta Framework for joint development of multiple Crusoe AI focused data centres co-sited… CISION PRNewswireFebruary 13, 2025
